Alligator Bioscience
BioStock: Alligator prepares for phase III with CD40 agonist
Read the interview with Sumeet Ambarkhane at biostock.se:
https://www.biostock.se/en/2024/02/alligator-prepares-for-phase-iii-with-cd40-agonist/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/
Datum | 2024-02-20, kl 08:36 |
Källa | Cision |
![](https://static.allaaktier.se/ads/hand-waving-2.png)